Chilton Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,263
Closed -$471K 218
2018
Q3
$471K Buy
5,263
+50
+1% +$4.42K 0.04% 171
2018
Q2
$414K Sell
5,213
-5,408
-51% -$449K 0.04% 179
2018
Q1
$947K Buy
10,621
+7,845
+283% +$753K 0.09% 134
2017
Q4
$290K Sell
2,776
-74,451
-96% -$8.4M 0.03% 156
2017
Q3
$11.3M Sell
77,227
-2,232
-3% -$304K 1.08% 35
2017
Q2
$10.3M Sell
79,459
-4,312
-5% -$528K 1.14% 38
2017
Q1
$10.4M Sell
83,771
-3,357
-4% -$402K 1.03% 40
2016
Q4
$10.1M Sell
87,128
-920
-1% -$102K 1.06% 42
2016
Q3
$9.2M Sell
88,048
-38,537
-30% -$4.17M 0.93% 49
2016
Q2
$12.5M Buy
126,585
+8,665
+7% +$896K 1.21% 33
2016
Q1
$11.8M Buy
117,920
+14,767
+14% +$1.52M 1.18% 34
2015
Q4
$12.4M Sell
103,153
-33,228
-24% -$3.84M 1.3% 23
2015
Q3
$14.8M Buy
136,381
+40,221
+42% +$4.99M 1.52% 17
2015
Q2
$11.1M Buy
96,160
+93,231
+3,183% +$10.7M 1.05% 34
2015
Q1
$338K Sell
2,929
-1,845
-39% -$220K 0.03% 143
2014
Q4
$534K Buy
4,774
+1,944
+69% +$205K 0.05% 135
2014
Q3
$268K Buy
+2,830
New +$255K 0.03% 141
2014
Q1
Sell
-3,900
Closed -$329K 369
2013
Q4
$329K Hold
3,900
0.04% 161
2013
Q3
$301K Hold
3,900
0.03% 171
2013
Q2
$228K Buy
+3,900
New +$235K 0.03% 186

Other funds holding CELG

Chilton Capital Management's CELG Position: Q4 2018 in Review

Chilton Capital Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 5,263 shares — an estimated $471K sold.

Chilton Capital Management first reported a position in CELG in Q2 2013 and held it in 20 quarters. The position peaked at $14.8M in Q3 2015. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Chilton Capital Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Chilton Capital Management sold 5,263 Celgene Corp shares in Q4 2018, an estimated $471K.
  • Chilton Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 20 quarters.
  • Chilton Capital Management's Celgene Corp position peaked at $14.8M in Q3 2015.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Chilton Capital Management's 13F filing for Q4 2018, filed 12 Feb 2019.